Synthesis and Evaluation of Novel 68 Ga-Labeled GRPR-Targeted PET Tracers Derived from [ d -Phe 6 ,Pro 14 ]Bombesin(6–14) and [ d -Phe 6 ,des-Met 14 ]Bombesin(6–14) Sequences
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Shireen Jozi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada. Hauptthemen laut MEDLINE: Receptors, Bombesin, Gallium Radioisotopes, Bombesin, Positron-Emission Tomography. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Gastrin-releasing peptide receptor (GRPR) is a G-protein-coupled receptor that is overexpressed in several malignancies, rendering it an ideal target for cancer imaging and therapy. In this report, we conducted structure–activity relationship studies by optimizing the substitution of Pro 14 based on an agonist sequence, [ d -Phe 6,Pro 14 ]Bombesin(6–14), and optimizing the substitution of the C -terminal Leu 13 -NH 2 based on an antagonist sequence, [ d -Phe 6,des-Met 14 ]Bombesin(6–14). PEP-1–PEP-5 derived from the agonist sequence and PEP-6–PEP-14 derived from the antagonist sequence were synthesized by a solid-phase approach and were obtained in 10–60% yield. In vitro competition binding assays showed that the K i values of PEP-1–PEP-14 were in the range of 1.16 nM to 266 nM. PEP-3, PEP-4, PEP-8, PEP-9, and PEP-10 with K i < 6 nM were selected for elongation with Ga-DOTA complex and Pip linker at their N -terminus. Calcium release assays confirmed the agonist-antagonist nature of Ga-DOTA-Pip-conjugated peptides. Ga-DOTA-Pip-PEP-4, Ga-DOTA-Pip-PEP-9, and Ga-DOTA-Pip-PEP-10 retaining high GRPR binding affinity (K i < 10 nM) were selected for 68 Ga labeling for further evaluation. [ 68 Ga]Ga-DOTA-Pip-PEP-4, [ 68 Ga]Ga-DOTA-Pip-PEP-9, and [ 68 Ga]Ga-DOTA-Pip-PEP-10 were obtained in 16–44% decay-corrected radiochemical yields with ≥64 GBq/μmol molar activity and ≥ 97% radiochemical purity. PET imaging and ex vivo biodistribution studies were conducted in PC-3 tumor-bearing mice at 1 h postinjection. All [ 68 Ga]Ga-DOTA-Pip-PEP-4, [ 68 Ga]Ga-DOTA-Pip-PEP-9, and [ 68 Ga]Ga-DOTA-Pip-PEP-10 were excreted mainly via the renal pathway and enabled clear visualization of tumor xenografts in PET images with good tumor-to-background contrast. The pancreas uptake of the agonist tracer, [ 68 Ga]Ga-DOTA-Pip-PEP-4, was much lower than that of the clinically evaluated agonist tracer, [ 68 Ga]Ga-AMBA. Similarly, the pancreas uptake of the antagonist tracers, [ 68 Ga]Ga-DOTA-Pip-PEP-9, and [ 68 Ga]Ga-DOTA-Pip-PEP-10, was also much lower than that of the clinically evaluated antagonist tracers, [ 68 Ga]Ga-RM2, [ 68 Ga]Ga-SB3, and [ 68 Ga]Ga-NeoB. Our data demonstrate that the sequences of Ga-DOTA-Pip-PEP-4, Ga-DOTA-Pip-PEP-9, and Ga-DOTA-Pip-PEP-10 are promising templates for the development of radiopharmaceuticals targeting GRPR-expressing cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
- Department of Molecular Imaging and Therapy, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
- Department of Radiology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
ORCID-Profile: François Bénard, Kuo-Shyan Lin
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Jozi, S., Pathania, S., Wang, L., Chen, C. C., Lau, W. S., Ng, P., Merkens, H., Bénard, F., & Lin, K. S. (2026). Synthesis and Evaluation of Novel 68 Ga-Labeled GRPR-Targeted PET Tracers Derived from [ d -Phe 6 ,Pro 14 ]Bombesin(6–14) and [ d -Phe 6 ,des-Met 14 ]Bombesin(6–14) Sequences. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01683
Vancouver
Jozi S, Pathania S, Wang L, Chen CC, Lau WS, Ng P, et al. Synthesis and Evaluation of Novel 68 Ga-Labeled GRPR-Targeted PET Tracers Derived from [ d -Phe 6 ,Pro 14 ]Bombesin(6–14) and [ d -Phe 6 ,des-Met 14 ]Bombesin(6–14) Sequences. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01683
BibTeX
@article{Jozi2026,
author = {Jozi, Shireen and Pathania, Sheetal and Wang, Lei and Chen, Chao-Cheng and Lau, Wing Sum and Ng, Pauline and Merkens, Helen and Bénard, François and Lin, Kuo-Shyan},
title = {Synthesis and Evaluation of Novel 68 Ga-Labeled GRPR-Targeted PET Tracers Derived from [ d -Phe 6 ,Pro 14 ]Bombesin(6–14) and [ d -Phe 6 ,des-Met 14 ]Bombesin(6–14) Sequences},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01683}
}
EUVIMED